Christopher Altomare

Christopher Altomare has had a varied and impressive career. Christopher began their professional experience in 2008 as a Freelance Graphic and Web Designer. In 2009, they were a Peer Tutor at Alvernia University Learning Center. In 2010, they were a Clinical and Research Intern at Reading Hospital and in 2011 they were a Surgical Intern at Reading Hospital. In 2012, they were a Research Assistant at Alvernia University and a Director, Clinical Development & Pharmaceutical Services at DRUGSCAN. In 2021, they became the Deputy Study Director, Category One Testing at Adare Pharma Solutions and in 2018 they became the CEO of Nova Analytic Labs.

Christopher Altomare began their educational journey in 2008 by attending Boston University for a year of Biochemistry. Christopher then attended Alvernia University from 2009 to 2012, where they earned a Bachelor of Science in Biochemistry. In 2018, they began attending Thomas Jefferson University, where they are currently studying Cannabinoid Chemistry, Toxicology, Pharmacology, and Medicine.